0001209191-21-038932.txt : 20210608
0001209191-21-038932.hdr.sgml : 20210608
20210608163813
ACCESSION NUMBER: 0001209191-21-038932
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210604
FILED AS OF DATE: 20210608
DATE AS OF CHANGE: 20210608
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: O'Donnell Niall
CENTRAL INDEX KEY: 0001780235
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38981
FILM NUMBER: 211002578
MAIL ADDRESS:
STREET 1: C/O RIVERVEST VENTURE PARTNERS
STREET 2: 101 SOUTH HANLEY RD., STE 1850
CITY: ST. LOUIS
STATE: MO
ZIP: 63105
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Mirum Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001759425
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 831281555
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 950 TOWER LANE, SUITE 1050
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
BUSINESS PHONE: 650-667-4085
MAIL ADDRESS:
STREET 1: 950 TOWER LANE, SUITE 1050
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-06-04
0
0001759425
Mirum Pharmaceuticals, Inc.
MIRM
0001780235
O'Donnell Niall
C/O RIVERVEST VENTURE PARTNERS
101 SOUTH HANLEY ROAD, STE. 1850
ST. LOUIS
MO
63105
1
0
0
0
Stock Option (right to buy)
16.88
2021-06-04
4
A
0
17000
0.00
A
2031-06-03
Common Stock
17000
17000
D
The shares vest on the first anniversary of the grant date, provided that the option will in any case be fully vested on the date of the Company's 2022 annual stockholder meeting.
Jody Howe, Attorney-in-Fact
2021-06-08